1. World Health Organization. Leishmaniasis. [https://www.who.int/leishmaniasis/burden/en/].
2. Martins VT, Duarte MC, Chávez-Fumagalli MA, Menezes-Souza D, Coelho CS, de Magalhães-Soares DF, Fernandes AP, Soto M, Tavares CA, Coelho EA. A Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis. Parasit Vectors. 2015;8(1):1–12.
3. Abbaszadeh-Afshar MJ, Mohebali M, Sharifi I, Akhoundi B, Aflatoonian MR, Bahreini MS, Mahmoudvand H. Seroepidemiological survey of visceral leishmaniasis among nomadic tribes of Kerman province, southeastern Iran: An observational study for implication to health policy. J Biostat Epidemiol. 2015;1(3/4):105–11.
4. Shokri A, Fakhar M, Teshnizi SH. Canine visceral leishmaniasis in Iran: A systematic review and meta-analysis. Acta trop. 2017;165:76–89.
5. Abbaszadeh-Afshar MJ, Sharifi I, Bamorovat M, Mohebali M, Bahreini MS, Naderi A. Canine visceral leishmaniasis; A seroepidemiological survey in Jiroft district, southern Kerman province, southeastern Iran in 2015. Iran J Parasitol. 2018;13(1):67–71.